##### Table of Contents



SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

[X]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2001

OR

[]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the transition period from _____________ to _____________.

COMMISSION FILE NUMBER: 333-94521

IASIS HEALTHCARE CORPORATION
(Exact Name of Registrant as Specified in Its Charter)

|                                                                        |  |                                                 
|----------------------------------------------------------------------- |  | ------------------------------------------------
|DELAWARE
(State or Other Jurisdiction of
Incorporation or Organization) |  | 76-0450619
(I.R.S. Employer
(Identification No.)

113 SEABOARD LANE, SUITE A-200
FRANKLIN, TENNESSEE 37067
(Address of Principal Executive Offices)

(615) 844-2747
(Registrants Telephone Number, Including Area Code)

Not Applicable
(Former Name, Former Address and Former Fiscal Year,
if Changed Since Last Report)

Indicate by check mark whether the registrant: (1) has filed
all reports required to be filed by Section 13 or 15 (d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days. YES [x]NO []

As of February 12, 2002, 31,955,863 shares of the Registrants
Common Stock were outstanding.





---

TABLE OF CONTENTS



|                                                                   |                                                                                               |  |  |  |  |  |  | 
|------------------------------------------------------------------ | --------------------------------------------------------------------------------------------- |  |  |  |  |  |  | 
|PART I FINANCIAL INFORMATION                                      
|                                                                   | Item 1. Financial Statements                                                                 
|CONDENSED AND CONSOLIDATED BALANCE SHEETS                         
|CONDENSED AND CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)   
|CONDENSED AND CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)   
|NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED FINANCIAL STATEMENTS
|                                                                   | Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
|                                                                   | Item 3. Quantitative and Qualitative Disclosures About Market Risk                           
|PART II OTHER INFORMATION                                         
|                                                                   | Item 2. Changes in Securities and Use of Proceeds.                                           
|                                                                   | Item 6. Exhibits and Reports on Form 8-K                                                     
|SIGNATURES                                                        
|EXHIBIT INDEX                                                     
|SENIOR EXECUTIVE COMPENSATION PLAN                                
|ODESSA REGIONAL HOSPITAL,LP UNAUDITED STATEMENTS                  



---



##### Table of Contents



TABLE OF CONTENTS

|                                |  |                                                                                               |                                                                                                                  |  |    |   | 
|------------------------------- |  | --------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------- |  | -- | - | 
|PART I   FINANCIAL INFORMATION |  |                                                                                               | 1                                                                                                                | 
|                                |  | Item 1. Financial Statements:                                                                 |                                                                                                                  |  | 1  |  
|                                |  |                                                                                               | Condensed and Consolidated Balance Sheets  December 31,
2001 (Unaudited) and September 30, 2001                 |  |    | 1 | 
|                                |  |                                                                                               | Condensed and Consolidated Statements of Operations

(Unaudited)  Three Months Ended December 31, 2001 and
2000 |  |    | 2 | 
|                                |  |                                                                                               | Condensed and Consolidated Statements of Cash Flows
(Unaudited)  Three Months Ended December 31, 2001 and
2000  |  |    | 3 | 
|                                |  |                                                                                               | Notes to Unaudited Condensed and Consolidated Financial Statements                                               |  |    | 4 | 
|                                |  | Item 2. Managements Discussion and Analysis of Financial Condition
and Results of Operations |                                                                                                                  |  | 13 |  
|                                |  | Item 3. Quantitative and Qualitative Disclosures About Market Risk                            |                                                                                                                  |  | 21 |  
|PART II. OTHER INFORMATION      |  |                                                                                               | 21                                                                                                               | 
|                                |  | Item 2. Changes in Securities and Use of Proceeds                                             |                                                                                                                  |  | 21 |  
|                                |  | Item 6. Exhibits and Reports on Form 8-K                                                      |                                                                                                                  |  | 22 |  





---



##### Table of Contents






PART I
FINANCIAL INFORMATION




Item 1.  Financial Statements




IASIS HEALTHCARE CORPORATION

CONDENSED AND CONSOLIDATED BALANCE SHEETS
(In thousands except share amounts)

|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |               |         |         |  | 
|-------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------ | ------------------------- | ------------------------------------ | ------- | ------------ | ------- | ------------- | ------- | ------- |  | 
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         | (Unaudited)  |         |               |         |        
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         | December 31, |         | September 30,
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         | 2001         |         | 2001         
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           | ASSETS                               |         |              |         |               |         |         |  | 
|Current assets:                                                      |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     | Cash and cash equivalents                                                                                                                                                                                                        |                                            | $                         |                                     |         |              | $       | 6,056         |        
|                                                                     | Accounts receivable, net of allowance for doubtful accounts of
$29,971 and $25,945, respectively                                                                                                                                 |                                            |                           | 147,313                              |         |              |         | 147,810       |        
|                                                                     | Inventories                                                                                                                                                                                                                      |                                            |                           | 22,624                               |         |              |         | 21,891        |        
|                                                                     | Prepaid expenses and other current assets                                                                                                                                                                                        |                                            |                           | 20,368                               |         |              |         | 15,454        |        
|                                                                     | Assets held for sale                                                                                                                                                                                                             |                                            |                           | 22,378                               |         |              |         | 25,106        |        
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     |                                                                                                                                                                                                                                  |                                            | Total current assets      |                                      |         | 212,683      |         |               |         | 216,317 | 
|Property and equipment, net                                          |                                                                                                                                                                                                                                  |                                            | 391,042                   |                                      |         |              | 335,037 |              
|Goodwill and other intangibles, net                                  |                                                                                                                                                                                                                                  |                                            | 292,606                   |                                      |         |              | 292,304 |              
|Deferred debt financing costs, net                                   |                                                                                                                                                                                                                                  |                                            | 21,034                    |                                      |         |              | 19,768  |              
|Other assets                                                         |                                                                                                                                                                                                                                  |                                            | 3,190                     |                                      |         |              | 2,883   |              
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     |                                                                                                                                                                                                                                  |                                            | Total assets              |                                      | $       | 920,555      |         |               | $       | 866,309 | 
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           | LIABILITIES AND STOCKHOLDERS EQUITY
|Current liabilities:                                                 |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     | Accounts payable                                                                                                                                                                                                                 |                                            | $                         | 49,363                               |         |              | $       | 48,062        |        
|                                                                     | Salaries and benefits payable                                                                                                                                                                                                    |                                            |                           | 18,010                               |         |              |         | 16,806        |        
|                                                                     | Accrued interest payable                                                                                                                                                                                                         |                                            |                           | 9,801                                |         |              |         | 18,297        |        
|                                                                     | Medical claims payable                                                                                                                                                                                                           |                                            |                           | 25,000                               |         |              |         | 21,871        |        
|                                                                     | Other accrued expenses and other current liabilities                                                                                                                                                                             |                                            |                           | 20,026                               |         |              |         | 21,647        |        
|                                                                     | Current portion of accrued loss on discontinued operations                                                                                                                                                                       |                                            |                           | 391                                  |         |              |         | 396           |        
|                                                                     | Current portion of long-term debt and capital lease
obligations                                                                                                                                                                  |                                            |                           | 19,814                               |         |              |         | 19,603        |        
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     |                                                                                                                                                                                                                                  |                                            | Total current liabilities |                                      |         | 142,405      |         |               |         | 146,682 | 
|Long-term debt and capital lease obligations, net of current portion |                                                                                                                                                                                                                                  |                                            | 589,049                   |                                      |         |              | 530,574 |              
|Other long-term liabilities                                          |                                                                                                                                                                                                                                  |                                            | 17,694                    |                                      |         |              | 18,380  |              
|Minority interest                                                    |                                                                                                                                                                                                                                  |                                            | 4,602                     |                                      |         |              | 4,379   |              
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     |                                                                                                                                                                                                                                  |                                            | Total liabilities         |                                      |         | 753,750      |         |               |         | 700,015 | 
|Stockholders equity                                                
|                                                                     | Common stock  $0.01 par value, authorized 100,000,000 shares;
31,984,779 shares issued and 31,955,863 shares outstanding
at December 31, 2001; 31,961,445 shares issued and
31,932,529 shares outstanding at September 30, 2001 |                                            |                           | 320                                  |         |              |         | 320           |        
|                                                                     | Additional paid-in capital                                                                                                                                                                                                       |                                            |                           | 450,718                              |         |              |         | 450,496       |        
|                                                                     | Treasury stock, at cost, 16,306,541 shares at December 31, 2001
and September 30, 2001                                                                                                                                           |                                            |                           | (155,300                             | )       |              |         | (155,300      | )      
|                                                                     | Accumulated deficit                                                                                                                                                                                                              |                                            |                           | (128,933                             | )       |              |         | (129,222      | )      
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     |                                                                                                                                                                                                                                  | Total stockholders equity                 |                           |                                      | 166,805 |              |         |               | 166,294 |        
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              
|                                                                     |                                                                                                                                                                                                                                  | Total liabilities and stockholders equity |                           | $                                    | 920,555 |              |         | $             | 866,309 |        
|                                                                     |                                                                                                                                                                                                                                  |                                            |                           |                                      |         |              |         |              

See accompanying notes.

1



---



##### Table of Contents






IASIS HEALTHCARE CORPORATION
CONDENSED AND CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands)

|                                                                           |                               |                          |         |                    |         |      |         |        |         |  
|-------------------------------------------------------------------------- | ----------------------------- | ------------------------ | ------- | ------------------ | ------- | ---- | ------- | ------ | ------- | -
|                                                                           |                               |                          |         | Three Months Ended
|                                                                           |                               |                          |         | December 31,      
|                                                                           |                               |                          |         |                   
|                                                                           |                               |                          |         | 2001               |         | 2000
|                                                                           |                               |                          |         |                    |         |     
|Net revenue                                                                |                               | $                        | 220,881 |                    |         | $    | 219,369 |       
|Costs and expenses:                                                        |                               |                          |         |                    |         |      |         |       
|                                                                           | Salaries and benefits         |                          |         | 77,727             |         |      |         | 77,085 |        
|                                                                           | Supplies                      |                          |         | 31,293             |         |      |         | 32,136 |        
|                                                                           | Other operating expenses      |                          |         | 69,584             |         |      |         | 64,995 |        
|                                                                           | Provision for bad debts       |                          |         | 16,774             |         |      |         | 17,395 |        
|                                                                           | Interest, net                 |                          |         | 14,503             |         |      |         | 17,208 |        
|                                                                           | Depreciation and amortization |                          |         | 10,488             |         |      |         | 14,108 |        
|                                                                           |                               |                          |         |                    |         |      |         |       
|                                                                           |                               | Total costs and expenses |         |                    | 220,369 |      |         |        | 222,927 |  
|                                                                           |                               |                          |         |                    |         |      |         |       
|Earnings (loss) from operations before minority
interests and income taxes |                               |                          | 512     |                    |         |      | (3,558  | )     
|Minority interests                                                         |                               |                          | 223     |                    |         |      | 53      |       
|                                                                           |                               |                          |         |                    |         |      |         |       
|Earnings (loss) from operations before income taxes                        |                               |                          | 289     |                    |         |      | (3,611  | )     
|Income tax expense                                                         |                               |                          |        |                    |         |      |        |       
|                                                                           |                               |                          |         |                    |         |      |         |       
|                                                                           |                               | Net earnings (loss)      |         |                    | 289     |      |         |        | (3,611  | )
|Preferred stock dividends reversed                                         |                               |                          |        |                    |         |      | (25,348 | )     
|                                                                           |                               |                          |         |                    |         |      |         |       
|Net earnings attributable to common stockholders                           |                               | $                        | 289     |                    |         | $    | 21,737  |       
|                                                                           |                               |                          |         |                    |         |      |         |       

See accompanying notes.

2



---



##### Table of Contents






IASIS HEALTHCARE CORPORATION
CONDENSED AND CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)

|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |         |         |         |         |  
|-------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------- | ------------------------------------------------------- | --------------------------------------------------- | ------------------------------------------------------ | - | ------------------ | ------ | ------- | ------- | ------- | ------- | -
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   | Three Months Ended
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   | December 31,      
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                   
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   | 2001               |        | 2000   
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|Cash flows from operating activities:                                |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     | Net earnings (loss)                                                                                  |                                                         | $                                                   | 289                                                    |   |                    | $      | (3,611  | )      
|                                                                     | Adjustments to reconcile net earnings (loss) to net cash
provided by (used in) operating activities: |                                                         |                                                     |                                                        |   |                    |        |         |        
|                                                                     |                                                                                                      |                                                         | Depreciation and amortization                       |                                                        |   | 10,488             |        |         |         | 14,108  |        
|                                                                     |                                                                                                      |                                                         | Minority interests                                  |                                                        |   | 223                |        |         |         | 53      |        
|                                                                     |                                                                                                      |                                                         | Gain on sale of property and equipment              |                                                        |   | (12                | )      |         |         |        |        
|                                                                     |                                                                                                      |                                                         | Changes in operating assets and liabilities:        |                                                        |   |                    |        |         |         |         |        
|                                                                     |                                                                                                      |                                                         |                                                     | Accounts receivable                                    |   |                    | 712    |         |         |         | (19,205 | )
|                                                                     |                                                                                                      |                                                         |                                                     | Inventories, prepaid expenses and other
current assets |   |                    | (5,757 | )       |         |         | (2,408  | )
|                                                                     |                                                                                                      |                                                         |                                                     | Accounts payable and other accrued liabilities         |   |                    | (5,407 | )       |         |         | 6,095   |  
|                                                                     |                                                                                                      |                                                         |                                                     | Accrued loss on discontinued operations                |   |                    | (239   | )       |         |         | (1,034  | )
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     |                                                                                                      |                                                         | Net cash provided by (used in) operating activities |                                                        |   | 297                |        |         |         | (6,002  | )      
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|Cash flows from investing activities:                                |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     | Purchases of property and equipment                                                                  |                                                         |                                                     | (62,283                                                | ) |                    |        | (9,391  | )      
|                                                                     | Proceeds from sale of property and equipment                                                         |                                                         |                                                     | 12                                                     |   |                    |        |        |        
|                                                                     | Change in other assets                                                                               |                                                         |                                                     | (665                                                   | ) |                    |        | (907    | )      
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     |                                                                                                      |                                                         | Net cash used in investing activities               |                                                        |   | (62,936            | )      |         |         | (10,298 | )      
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|Cash flows from financing activities:                                |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     | Proceeds from issuance of common stock                                                               |                                                         |                                                     | 222                                                    |   |                    |        | 1,620   |        
|                                                                     | Proceeds from senior bank debt borrowings                                                            |                                                         |                                                     | 94,600                                                 |   |                    |        | 45,600  |        
|                                                                     | Payment of debt and capital leases                                                                   |                                                         |                                                     | (35,914                                                | ) |                    |        | (30,920 | )      
|                                                                     | Debt financing costs incurred                                                                        |                                                         |                                                     | (2,325                                                 | ) |                    |        |        |        
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     |                                                                                                      |                                                         | Net cash provided by financing activities           |                                                        |   | 56,583             |        |         |         | 16,300  |        
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|Decrease in cash and cash equivalents                                |                                                                                                      |                                                         | (6,056                                              | )                                                      |   |                    |       |        
|Cash and cash equivalents at beginning of period                     |                                                                                                      |                                                         | 6,056                                               |                                                        |   |                    |       |        
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|Cash and cash equivalents at end of period                           |                                                                                                      | $                                                       |                                                    |                                                        |   | $                  |       |        
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|Supplemental disclosure of cash flow information:                    |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     |                                                                                                      |                                                         | Cash paid for interest                              |                                                        | $ | 22,931             |        |         | $       | 24,492  |        
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     |                                                                                                      |                                                         | Cash paid for income taxes                          |                                                        | $ |                   |        |         | $       | 3,250   |        
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|Supplemental schedule of noncash investing and
financing activities: |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     |                                                                                                      | Capital lease obligations incurred to acquire equipment |                                                     | $                                                      |  |                    |        |         | 600     |        
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        
|                                                                     |                                                                                                      | Exchange of preferred stock for common stock            |                                                     | $                                                      |  |                    |        | $       | 189,278 |        
|                                                                     |                                                                                                      |                                                         |                                                     |                                                        |   |                    |        |        

See accompanying notes.

3



---



##### Table of Contents






IASIS HEALTHCARE CORPORATION
NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED
FINANCIAL STATEMENTS

1.     Basis of Presentation

The unaudited condensed and consolidated financial statements include the
accounts of IASIS Healthcare Corporation (IASIS or the Company) and all
subsidiaries and entities under common control of the Company and have been
prepared in accordance with accounting principles generally accepted in the
United States for interim financial reporting and in accordance with Rule 10-01
of Regulation S-X. Accordingly, they do not include all of the information and
notes required by accounting principles generally accepted in the United States
for complete financial statements. The balance sheet at September 30, 2001 has
been derived from the audited financial statements at that date but does not
include all of the information and footnotes required by accounting principles
generally accepted in the United States for complete financial statements. For
further information, refer to the consolidated and combined financial
statements and footnotes thereto included in the Companys Annual Report on
Form 10-K for the fiscal year ended September 30, 2001.

In the opinion of management, the accompanying unaudited condensed and
consolidated financial statements contain all material adjustments (consisting
of normal recurring items) necessary for a fair presentation of results for the
interim periods presented. The results of operations for any interim period are
not necessarily indicative of results for the full year.

The preparation of the financial statements in conformity with accounting
principles generally accepted in the United States requires management to make
estimates and assumptions that affect the amounts reported in the accompanying
unaudited condensed and consolidated financial statements and notes. Actual
results could differ from those estimates.

IASIS operates networks of medium-sized hospitals in high-growth urban and
suburban markets. At December 31, 2001, the Company owned or leased 14
hospitals with a total of 2,092 beds in service. The Companys hospitals are
located in four regions:



| |  |  | Salt Lake City, Utah;                                     
| | - |  | ----------------------------------------------------------
|
| |  |  | Phoenix, Arizona;                                         
|
| |  |  | Tampa-St. Petersburg, Florida; and                        
|
| |  |  | three cities in the State of Texas, including San Antonio.

The Company also operates five ambulatory surgery centers and a Medicaid
managed health plan in Phoenix called Health Choice, serving over 53,800
members at December 31, 2001.

2.     Long-Term Debt and Capital Lease Obligations

Long-term debt and capital lease obligations
consist of the following (in thousands):

|                          |  |              |         |               |  |   |         | 
|------------------------- |  | ------------ | ------- | ------------- |  | - | ------- | 
|                          |  | December 31, |         | September 30,
|                          |  | 2001         |         | 2001         
|                          |  |              |         |              
|Bank facilities           |  | $            | 378,125 |               |  | $ | 319,375 | 
|Senior subordinated notes |  |              | 230,000 |               |  |   | 230,000 | 
|Capital lease obligations |  |              | 738     |               |  |   | 802     | 
|                          |  |              |         |               |  |   |         | 
|                          |  |              | 608,863 |               |  |   | 550,177 | 
|Less current maturities   |  |              | 19,814  |               |  |   | 19,603  | 
|                          |  |              |         |               |  |   |         | 
|                          |  | $            | 589,049 |               |  | $ | 530,574 | 
|                          |  |              |         |               |  |   |         | 

4



---



##### Table of Contents



IASIS HEALTHCARE CORPORATION
NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED
FINANCIAL STATEMENTS
(Continued)

Bank Facilities

Under a credit facility dated October 15, 1999, a syndicate of lenders
made a total of $455.0 million available to the Company in the form of an $80.0
million tranche A term loan, a $250.0 million tranche B term loan and a $125.0
million revolving credit facility (collectively, the Bank Facilities).
Effective October 5, 2001, the Company amended its Bank Facilities. The
amended Bank Facilities provide for an additional $30.0 million incremental
term loan on substantially the same terms and conditions as the Companys
existing Bank Facilities. The amended Bank Facilities also provide for
revisions to certain financial covenants.

On October 15, 2001, the Company acquired the land and buildings at two of
its hospitals previously operated under long-term leases for an aggregate
purchase price of approximately $55.3 million. The purchase price was financed
by the $30.0 million new incremental term loan and borrowings under the
Companys revolving credit facility.

At December 31, 2001, amounts outstanding under the tranche A, tranche B
and incremental term loans were approximately $68.8 million, $244.4 million and
$30.0 million, respectively. At December 31, 2001, the Company had drawn
$35.0 million under the revolving credit facility and had issued approximately
$30.5 million in letters of credit, resulting in remaining availability under
the revolving credit facility of approximately $59.5 million. The revolving
credit facility includes a $75.0 million sub-limit for letters of credit that
may be issued by the Company. Repayments under the term loans are due in
quarterly installments. In addition, the loans under the Bank Facilities are
subject to mandatory prepayment under specific circumstances, including from a
portion of excess cash flow and the net proceeds of specified casualty events,
asset sales and debt issuances, each subject to various exceptions. The loans
under the Bank Facilities bear interest at variable rates at specified margins
above either Morgan Guaranty Trust Company of New Yorks alternate base rate or
its reserve-adjusted Eurodollar rate. The weighted average interest rate on
outstanding borrowings under the Bank Facilities was approximately 6.9% for the
quarter ended December 31, 2001. The Company also pays a commitment fee equal
to 0.5% of the average daily amount available under the revolving credit
facility.

The Bank Facilities require the Company to comply with various financial
ratios and tests and contain covenants limiting the Companys ability to, among
other things, incur debt, engage in acquisitions or mergers, sell assets, make
investments or capital expenditures, make distributions or stock repurchases
and pay dividends. The Bank Facilities are guaranteed by the Companys
subsidiaries and these guaranties are secured by a pledge of substantially all
of the subsidiaries assets. Substantially all of the Companys outstanding
common stock is pledged for the benefit of the Companys lenders as security
for the Companys obligations under the Bank Facilities.

Senior Subordinated Notes

On October 13, 1999, the Company issued $230.0 million of 13% senior
subordinated notes due 2009. On May 25, 2000, the Company exchanged all of its
outstanding 13% senior subordinated notes due 2009 for 13% senior subordinated
exchange notes due 2009 that have been registered under the Securities Act of
1933, as amended (the Notes). Terms and conditions of the exchange offer
were as set forth in the registration statement on Form S-4 filed with the
Securities and Exchange Commission that became effective on April 17, 2000.
The Notes are unsecured obligations and are subordinated in right of payment to
all existing and future senior indebtedness of the Company. Interest on the
Notes is payable semi-annually.

Except with respect to a change of control, the Company is not required to
make mandatory redemption or sinking fund payments with respect to the Notes.
The Notes are guaranteed, jointly and severally, by all of the Companys
subsidiaries (Subsidiary Guarantors). The Company is a holding company with
no independent assets or operations apart from its ownership of the Subsidiary
Guarantors. At December 31, 2001, all of the Subsidiary Guarantors fully and
unconditionally guaranteed the Notes and, with the exception of Odessa Regional
Hospital, LP, all were 100% owned by the Company. The indenture for the Notes
contains certain covenants, including but not limited to, restrictions on new
indebtedness, asset sales, capital expenditures, dividends and the Companys
ability to merge or consolidate.

5



---



##### Table of Contents



IASIS HEALTHCARE CORPORATION
NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED
FINANCIAL STATEMENTS
(Continued)

3.     Preferred Stock

In October 1999, the Company acquired ten acute care hospitals and other
related facilities and assets from Tenet Healthcare Corporation (Tenet) for
approximately $431.8 million in cash and approximately $41.2 million in assumed
liabilities. Concurrent with the Tenet transaction, the Company issued 160,000
shares of mandatorily redeemable Series A preferred stock for proceeds, net of
issuance costs, of $158.6 million. In conjunction with the Tenet transaction,
a company formed by members of the Companys management merged with and into
the Company. In connection with the merger, the Company issued 5,311 shares of
mandatorily redeemable Series B preferred stock valued at an aggregate of $5.3
million, net of issuance costs. On October 26, 2000, all shares of the
Companys mandatorily redeemable Series A and Series B preferred stock were
exchanged for shares of the Companys common stock on the basis of ten common
shares for each preferred share. The preferred stock was exchanged for common
stock without benefit to the preferred stockholders of the accrued dividends,
therefore, previously accrued preferred stock dividends were reversed. The
exchange increased the net earnings available for common stockholders and
stockholders equity by approximately $25.3 million and $189.3 million,
respectively.

4.     Contingencies

Net Revenue

The calculation of appropriate payments from the Medicare and Medicaid
programs as well as terms governing agreements with other third party payors
are complex and subject to interpretation. Final determination of amounts
earned under the Medicare and Medicaid programs often occurs subsequent to the
year in which services are rendered because of audits by the programs, rights
of appeal and the application of numerous technical provisions. As a result,
there is at least a reasonable possibility that recorded estimates will change
by a material amount in the near term. In the opinion of management, adequate
provision has been made for adjustments that may result from such routine
audits and appeals. The Company believes it is in material compliance with all
applicable laws and regulations and is not aware of any pending or threatened
investigations involving allegations of potential wrongdoing that would have a
material effect on its financial statements. Compliance with such laws and
regulations can be subject to future government review and interpretation as
well as significant regulatory action including fines, penalties, and exclusion
from the Medicare and Medicaid programs.

Professional, General and Workers Compensation Liability Risks

The Company is subject to claims and legal actions in the ordinary course
of business, including claims relating to patient treatment and personal
injuries. To cover these types of claims, the Company maintains general
liability and professional liability insurance in excess of self-insured
retentions through a commercial insurance carrier in amounts that the Company
believes to be sufficient for its operations, although, potentially, some
claims may exceed the scope of coverage in effect. Plaintiffs may request
punitive or other damages that may not be covered by insurance. The Company
expenses an actuarially determined estimate of the cost it expects to incur
under the self-insured retention exposure for professional liability claims.
The Company is currently not a party to any such proceedings that, in the
Companys opinion, would have a material adverse effect on the Companys
business, financial condition or results of operations.

The Company is subject to claims and legal actions in the ordinary course
of business relative to workers compensation and other labor and employment
matters. To cover these types of claims, the Company maintains workers
compensation insurance coverage with a self-insured retention. The Company
accrues costs of workers compensation claims based upon estimates derived from
its claims experience.

6



---



##### Table of Contents



IASIS HEALTHCARE CORPORATION
NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED
FINANCIAL STATEMENTS
(Continued)

Health Choice

Health Choice has entered into a capitated contract whereby the plan
provides healthcare services in exchange for fixed periodic and supplemental
payments from Arizona Health Care Cost Containment System (AHCCCS). These
services are provided regardless of the actual costs incurred to provide these
services. The Company receives reinsurance and other supplemental payments
from AHCCCS to cover certain costs of healthcare services that exceed certain
thresholds. The Company believes the capitated payments, together with
reinsurance and other supplemental payments, are sufficient to pay for the
services Health Choice is obligated to deliver. As of December 31, 2001, the
Company has provided performance guaranties in the form of a surety bond in the
amount of $9.4 million and a letter of credit in the amount of $11.2 million
for the benefit of AHCCCS to support its obligations under the Health Choice
contract to provide and pay for the healthcare services.

Tax Sharing Agreement

The Company and some of its subsidiaries are included in JLL Healthcare,
LLCs consolidated group for U.S. Federal income tax purposes as well as in
some consolidated, combined or unitary groups which include JLL Healthcare, LLC
for state, local and foreign income tax purposes. The Company and JLL
Healthcare, LLC have entered into a tax sharing agreement that requires the
Company to make payments to JLL Healthcare, LLC such that, with respect to tax
returns for any taxable period in which the Company or any of its subsidiaries
is included in JLL Healthcare, LLCs consolidated group or any combined group,
including JLL Healthcare, LLC, the amount of taxes to be paid by the Company
will be determined, subject to some adjustments, as if the Company and each of
its subsidiaries included in JLL Healthcare, LLCs consolidated group or a
combined group including JLL Healthcare, LLC filed their own consolidated,
combined or unitary tax return.

Each member of a consolidated group for U.S. Federal income tax purposes
is jointly and severally liable for the Federal income tax liability of each
other member of the consolidated group. Accordingly, although the tax sharing
agreement allocates tax liabilities between the Company and JLL Healthcare,
LLC, for any period in which the Company is included in JLL Healthcare, LLCs
consolidated group, the Company could be liable in the event that any Federal
tax liability was incurred, but not discharged, by any other member of JLL
Healthcare, LLCs consolidated group.

5.     Discontinued Operations

During the fourth quarter of fiscal 2000, the Company implemented plans to
sell its physician practice operations and close related practice support
offices, resulting in an estimated loss on sale and closure of $7.4 million in
the fiscal year ended September 30, 2000. During the fiscal year ended
September 30, 2001, $1.0 million of previously recorded loss accruals were
reversed due to discontinuing these operations at costs that were less than
previously estimated. During the three months ended December 31, 2001, the
Company completed exiting this business. At December 31, 2001, the remaining
accrual for estimated loss on sale and closure was $2.7 million and consisted
primarily of lease termination costs and physician contract termination costs.
Of this balance, approximately $2.3 million of costs are expected to be paid
subsequent to the next 12 months and are recorded within other long-term
liabilities in the accompanying condensed and consolidated balance sheets.

6.     Goodwill and Intangible Assets

The Company adopted Statement of Financial Accounting Standards (SFAS)
No. 142, Goodwill and Other Intangible Assets,effective October 1, 2001.
Under SFAS No. 142, goodwill and intangible assets deemed to have indefinite
lives will no longer be amortized but will be subject to impairment tests on an
annual basis, or more frequently if certain indicators arise. Other intangible
assets will continue to be amortized over their useful lives. The Company is
required to complete its transitional impairment test of existing goodwill by
March 31, 2002. As of the date hereof, the Company has not completed its
impairment testing of goodwill and has not yet determined what the effect of
these tests will be on the earnings and financial position of the Company.

7



---



##### Table of Contents



IASIS HEALTHCARE CORPORATION
NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED
FINANCIAL STATEMENTS
(Continued)

The following table sets forth the Companys goodwill and other intangible
assets at the periods indicated (in thousands):

|                                                                                      |                                     |   |              |         |               |   |         |         | 
|------------------------------------------------------------------------------------- | ----------------------------------- | - | ------------ | ------- | ------------- | - | ------- | ------- | 
|                                                                                      |                                     |   | December 31, |         | September 30,
|                                                                                      |                                     |   | 2001         |         | 2001         
|                                                                                      |                                     |   |              |         |              
|Goodwill, net of accumulated amortization
of $29,586 and $29,586, respectively        |                                     | $ | 292,039      |         |               | $ | 292,060 |        
|Other intangible assets, net of
accumulated amortization of $84 and $29,
respectively |                                     |   | 567          |         |               |   | 244     |        
|                                                                                      |                                     |   |              |         |               |   |         |        
|                                                                                      | Goodwill and other intangibles, net |   | $            | 292,606 |               |   | $       | 292,304 | 
|                                                                                      |                                     |   |              |         |               |   |         |        

Application of the nonamortization provisions of SFAS No. 142 is expected to
result in an increase to pre-tax net earnings of approximately $11.8 million
per year. For the three months ended December 31, 2000, excluding amortization
of goodwill of approximately $3.0 million, the net loss would have been
$600,000. Amortization expense on intangible assets was $55,000 and $0 for the
three months ended December 31, 2001 and 2000, respectively.

7.     Asset Revaluation and Closure Costs

During the year ended September 30, 2001, the Company recorded $11.9
million of pre-tax charges relating to asset revaluation and closure expenses
of Rocky Mountain Medical Center, which was closed on June 2, 2001.
Approximately $2.8 million of these charges related to the revaluation of Rocky
Mountain Medical Center net assets in conjunction with their classification as
held for sale. At December 31, 2001, Rocky Mountain Medical Center net assets
held for sale and expected to be sold no later than September 30, 2002,
consisted of property and equipment and totaled approximately $22.0 million,
net of the asset revaluation allowance.

The remaining $9.1 million charge related to the adoption and
implementation of an exit plan with respect to the closure of Rocky Mountain
Medical Center. This closure plan included the involuntary termination of
approximately 200 hospital and business office personnel, which was completed
by September 30, 2001. At December 31, 2001, accrued closure costs totaled
approximately $4.6 million. The following table summarizes the closure costs
payment activity for the three months ended December 31, 2001(in thousands):

|                               |          |   |               |      |             |   |                   |      |                  |   |       |      |   |   |     |      |   |   |       |        |  
|------------------------------ | -------- | - | ------------- | ---- | ----------- | - | ----------------- | ---- | ---------------- | - | ----- | ---- | - | - | --- | ---- | - | - | ----- | ------ | -
|                               |          |   |               |      |             |   | Facility and      |      |                  |   |       |      |   |   |     |      |   |   |      
|                               |          |   |               |      |             |   | Lease             |      |                  |   |       |      |   |   |     |      |   |   |      
|                               |          |   | Severance and |      | Termination |   | Contract          |      |                  |   |       |      |   |   |    
|                               |          |   | Related Costs |      | Costs       |   | Termination Costs |      | Other Exit Costs |   | Total
|                               |          |   |               |      |             |   |                   |      |                  |   |      
|Balances at September 30, 2001 |          | $ | 266           |      |             | $ | 2,749             |      |                  | $ | 1,968 |      |   | $ | 658 |      |   | $ | 5,641 |       
|                               | Payments |   |               | (225 | )           |   |                   | (397 | )                |   |       | (167 | ) |   |     | (273 | ) |   |       | (1,062 | )
|                               |          |   |               |      |             |   |                   |      |                  |   |       |      |   |   |     |      |   |   |       |       
|Balances at December 31, 2001  |          | $ | 41            |      |             | $ | 2,352             |      |                  | $ | 1,801 |      |   | $ | 385 |      |   | $ | 4,579 |       
|                               |          |   |               |      |             |   |                   |      |                  |   |       |      |   |   |     |      |   |   |       |       

Net revenue and pre-tax losses from Rocky Mountain Medical Center were
$4.1 million and $5.8 million, respectively, for the three months ended
December 31, 2000.

8.     Segment and Geographic Information

The Companys acute care hospitals and related health care businesses are
similar in their activities and the economic environments in which they operate
(i.e., urban and suburban markets). Accordingly, the Companys reportable
operating segments consist of (1) acute care hospitals and related healthcare
businesses, collectively, and (2) its Medicaid managed health plan, Health
Choice and a related entity (collectively referred to as Health Choice).The
following is a financial summary by business segment for the periods indicated:

8



---



##### Table of Contents



IASIS HEALTHCARE CORPORATION
NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED
FINANCIAL STATEMENTS
(Continued)

|                                       |                                                                     |   |                    |         |      |   |         |         |  
|-------------------------------------- | ------------------------------------------------------------------- | - | ------------------ | ------- | ---- | - | ------- | ------- | -
|                                       |                                                                     |   | Three Months      
|                                       |                                                                     |   | Ended December 31,
|                                       |                                                                     |   |                   
|                                       |                                                                     |   | 2001               |         | 2000
|                                       |                                                                     |   |                    |         |     
|                                       |                                                                     |   | (In thousands)    
|Acute Care Service:                    |                                                                     |   |                    |         |      |   |         |        
|Net patient revenue                    |                                                                     | $ | 189,148            |         |      | $ | 194,260 |        
|Revenue between segments               |                                                                     |   | (1,437             | )       |      |   | (1,663  | )      
|                                       |                                                                     |   |                    |         |      |   |         |        
|                                       | Net revenue                                                         |   |                    | 187,711 |      |   |         | 192,597 |  
|Salaries and benefits                  |                                                                     |   | 76,488             |         |      |   | 75,929  |        
|Supplies                               |                                                                     |   | 31,193             |         |      |   | 32,039  |        
|Other operating expenses               |                                                                     |   | 38,897             |         |      |   | 40,664  |        
|Provision for bad debts                |                                                                     |   | 16,774             |         |      |   | 17,395  |        
|                                       |                                                                     |   |                    |         |      |   |         |        
|                                       | EBITDA (1)                                                          |   |                    | 24,359  |      |   |         | 26,570  |  
|Interest expense, net                  |                                                                     |   | 14,551             |         |      |   | 17,208  |        
|Depreciation and amortization          |                                                                     |   | 10,459             |         |      |   | 14,054  |        
|                                       |                                                                     |   |                    |         |      |   |         |        
|                                       | Loss from operations before minority
interests and income taxes     |   |                    | (651    | )    |   |         | (4,692  | )
|Minority interests                     |                                                                     |   | 223                |         |      |   | 53      |        
|                                       |                                                                     |   |                    |         |      |   |         |        
|                                       | Loss from operations before income taxes                            |   | $                  | (874    | )    |   | $       | (4,745  | )
|                                       |                                                                     |   |                    |         |      |   |         |        
|Segment assets                         |                                                                     | $ | 904,763            |         |      | $ | 887,069 |        
|                                       |                                                                     |   |                    |         |      |   |         |        
|Health Choice:                         |                                                                     |   |                    |         |      |   |         |        
|Capitation premiums and other payments |                                                                     | $ | 33,170             |         |      | $ | 26,772  |        
|Revenue between segments               |                                                                     |   |                   |         |      |   |        |        
|                                       |                                                                     |   |                    |         |      |   |         |        
|                                       | Net revenue                                                         |   |                    | 33,170  |      |   |         | 26,772  |  
|Salaries and benefits                  |                                                                     |   | 1,239              |         |      |   | 1,156   |        
|Supplies                               |                                                                     |   | 100                |         |      |   | 97      |        
|Other operating expenses               |                                                                     |   | 30,687             |         |      |   | 24,331  |        
|Provision for bad debts                |                                                                     |   |                   |         |      |   |        |        
|                                       |                                                                     |   |                    |         |      |   |         |        
|                                       | EBITDA (1)                                                          |   |                    | 1,144   |      |   |         | 1,188   |  
|Interest income                        |                                                                     |   | (48                | )       |      |   |        |        
|Depreciation and amortization          |                                                                     |   | 29                 |         |      |   | 54      |        
|                                       |                                                                     |   |                    |         |      |   |         |        
|                                       | Earnings from operations before minority
interests and income taxes |   |                    | 1,163   |      |   |         | 1,134   |  
|Minority interests                     |                                                                     |   |                   |         |      |   |        |        
|                                       |                                                                     |   |                    |         |      |   |         |        
|                                       | Earnings from operations before income taxes                        |   | $                  | 1,163   |      |   | $       | 1,134   |  
|                                       |                                                                     |   |                    |         |      |   |         |        
|Segment assets                         |                                                                     | $ | 15,760             |         |      | $ | 4,002   |        
|                                       |                                                                     |   |                    |         |      |   |         |        



---

|(1) |  | EBITDA represents earnings from operations before interest expense,
minority interests, income taxes and depreciation and amortization.
|--- |  | ---------------------------------------------------------------------------------------------------------------------------------------

9.     Supplemental Condensed Consolidating Financial Information

The Notes described in Note 2 are fully and unconditionally guaranteed on
a joint and several basis by all of the Companys Subsidiary Guarantors.

A summarized condensed consolidating balance sheet at December 31, 2001
and condensed consolidating statement of operations and statement of cash flows
for the three months ended December 31, 2001 for the Company, segregating the
parent company issuer, the combined 100% owned Subsidiary Guarantors, the
non-100% owned Subsidiary Guarantor and eliminations, are found below. Separate
unaudited financial statements of the non-100% owned Subsidiary Guarantor,
Odessa Regional Hospital, LP (Odessa), are included as Exhibit 99.1 to the
Companys filing on Form 10-Q. On February 1, 2001, Odessa sold 11.2% of its
limited partner units, which reduced the Companys ownership accordingly.
However, Odessas guaranty continues to be full and unconditional with respect
to the Notes. Prior to this sale, all of the Companys Subsidiary Guarantors
were 100% owned, thus no condensed consolidating financial statements are
provided for prior periods.

9



---



##### Table of Contents



IASIS HEALTHCARE CORPORATION
NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED
FINANCIAL STATEMENTS
(Continued)

IASIS Healthcare Corporation

Condensed Consolidating Balance Sheet (unaudited)
December 31, 2001(in thousands)

|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |         |         |         | 
|---------------------------------------------- | -------------------------------------------------------------------- | --------------------------------------------------------------- | ------------------------- | ------- | ------- | ------- | -------- | -------- | --------------------- | ------- | ------------ | ------ | ------------ | ------ | --------- | ------- | ------- | ------- | ------- | ------- | ------- | ------- | 
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          | Subsidiary Guarantors
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                      
|                                               |                                                                      |                                                                 |                           |         | Parent  |         | 100%     |          | Non-100%              |         |              |        |              |        | Condensed
|                                               |                                                                      |                                                                 |                           |         | Issuer  |         | Owned    |          | Owned                 |         | Eliminations |        | Consolidated
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |             
|                                               |                                                                      | Assets                                                          |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |         |         |        
|Current assets:                                |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |        
|                                               |                                                                      | Cash and cash equivalents                                       |                           | $       |        |         |          | $        |                      |         |              | $      |             |        |           | $       |        |         |         | $       |        |        
|                                               |                                                                      | Accounts receivable, net                                        |                           |         |        |         |          |          | 138,928               |         |              |        | 8,385        |        |           |         |        |         |         |         | 147,313 |        
|                                               |                                                                      | Inventories                                                     |                           |         |        |         |          |          | 21,467                |         |              |        | 1,157        |        |           |         |        |         |         |         | 22,624  |        
|                                               |                                                                      | Prepaid expenses and other current assets                       |                           |         |        |         |          |          | 19,692                |         |              |        | 676          |        |           |         |        |         |         |         | 20,368  |        
|                                               |                                                                      | Assets held for sale                                            |                           |         |        |         |          |          | 22,378                |         |              |        |             |        |           |         |        |         |         |         | 22,378  |        
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |        
|                                               |                                                                      |                                                                 | Total current assets      |         |         |        |          |          |                       | 202,465 |              |        |              | 10,218 |           |         |         |        |         |         |         | 212,683 | 
|Property and equipment, net                    |                                                                      |                                                                 |                          |         |         |         | 372,854  |          |                       |         | 18,188       |        |              |        |          |         |         |         | 391,042 |        
|Net investment in and advances to subsidiaries |                                                                      |                                                                 | 892,630                   |         |         |         | (860,868 | )        |                       |         | 1,613        |        |              |        | (33,375   | )       |         |         |        |        
|Goodwill and other intangibles, net            |                                                                      |                                                                 |                          |         |         |         | 263,779  |          |                       |         | 28,827       |        |              |        |          |         |         |         | 292,606 |        
|Deferred debt financing costs, net             |                                                                      |                                                                 | 21,034                    |         |         |         |         |          |                       |         |             |        |              |        |          |         |         |         | 21,034  |        
|Other assets                                   |                                                                      |                                                                 |                          |         |         |         | 3,190    |          |                       |         |             |        |              |        |          |         |         |         | 3,190   |        
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |        
|                                               |                                                                      |                                                                 | Total assets              |         | $       | 913,664 |          |          | $                     | (18,580 | )            |        | $            | 58,846 |           |         | $       | (33,375 | )       |         | $       | 920,555 | 
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |        
|                                               |                                                                      | Liabilities and stockholders equity                            |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |         |         |        
|                                               | Current liabilities:                                                 |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |         |        
|                                               |                                                                      | Accounts payable                                                |                           | $       |        |         |          | $        | 46,997                |         |              | $      | 2,366        |        |           | $       |        |         |         | $       | 49,363  |        
|                                               |                                                                      | Salaries and benefits payable                                   |                           |         |        |         |          |          | 17,125                |         |              |        | 885          |        |           |         |        |         |         |         | 18,010  |        
|                                               |                                                                      | Accrued interest payable                                        |                           |         | 9,801   |         |          |          |                      |         |              |        |             |        |           |         |        |         |         |         | 9,801   |        
|                                               |                                                                      | Medical claims payable                                          |                           |         |        |         |          |          | 25,000                |         |              |        |             |        |           |         |        |         |         |         | 25,000  |        
|                                               |                                                                      | Other accrued expenses and other current liabilities            |                           |         |        |         |          |          | 20,005                |         |              |        | 21           |        |           |         |        |         |         |         | 20,026  |        
|                                               |                                                                      | Current portion of accrued loss on discontinued operations      |                           |         |        |         |          |          | 391                   |         |              |        |             |        |           |         |        |         |         |         | 391     |        
|                                               |                                                                      | Current portion of long-term debt and capital
lease obligations |                           |         | 19,606  |         |          |          | 208                   |         |              |        |             |        |           |         |        |         |         |         | 19,814  |        
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |        
|                                               |                                                                      |                                                                 | Total current liabilities |         |         | 29,407  |          |          |                       | 109,726 |              |        |              | 3,272  |           |         |         |        |         |         |         | 142,405 | 
|                                               | Long-term debt and capital lease obligations, net
of current portion |                                                                 |                           | 588,519 |         |         |          | 530      |                       |         |              | 33,375 |              |        |           | (33,375 | )       |         |         | 589,049 |        
|                                               | Other long-term liabilities                                          |                                                                 |                           |        |         |         |          | 17,694   |                       |         |              |       |              |        |           |        |         |         |         | 17,694  |        
|                                               | Minority interest                                                    |                                                                 |                           |        |         |         |          | 4,602    |                       |         |              |       |              |        |           |        |         |         |         | 4,602   |        
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |        
|                                               |                                                                      | Total liabilities                                               |                           |         | 617,926 |         |          |          | 132,552               |         |              |        | 36,647       |        |           |         | (33,375 | )       |         |         | 753,750 |        
|                                               | Stockholders equity                                                 |                                                                 |                           | 295,738 |         |         |          | (151,132 | )                     |         |              | 22,199 |              |        |           |        |         |         |         | 166,805 |        
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |        
|                                               |                                                                      | Total liabilities and stockholders equity                      |                           | $       | 913,664 |         |          | $        | (18,580               | )       |              | $      | 58,846       |        |           | $       | (33,375 | )       |         | $       | 920,555 |        
|                                               |                                                                      |                                                                 |                           |         |         |         |          |          |                       |         |              |        |              |        |           |         |         |         |         |        

10



---



##### Table of Contents



IASIS HEALTHCARE CORPORATION
NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED
FINANCIAL STATEMENTS
(Continued)

IASIS Healthcare Corporation

Condensed Consolidating Statement of Operations
for the Three Months Ended December 31, 2001 (unaudited)(in thousands)

|                                                                           |                                  |                          |      |         |     |       |         |                       |         |              |        |              |       |           |         |        |        |   |         |        |         | 
|-------------------------------------------------------------------------- | -------------------------------- | ------------------------ | ---- | ------- | --- | ----- | ------- | --------------------- | ------- | ------------ | ------ | ------------ | ----- | --------- | ------- | ------ | ------ | - | ------- | ------ | ------- | 
|                                                                           |                                  |                          |      |         |     |       |         | Subsidiary Guarantors
|                                                                           |                                  |                          |      |         |     |       |         |                      
|                                                                           |                                  |                          |      | Parent  |     | 100%  |         | Non-100%              |         |              |        |              |       | Condensed
|                                                                           |                                  |                          |      | Issuer  |     | Owned |         | Owned                 |         | Eliminations |        | Consolidated
|                                                                           |                                  |                          |      |         |     |       |         |                       |         |              |        |             
|Net revenue                                                                |                                  | $                        |     |         |     | $     | 210,160 |                       |         | $            | 10,935 |              |       | $         | (214    | )      |        | $ | 220,881 |       
|Costs and expenses:                                                        |                                  |                          |      |         |     |       |         |                       |         |              |        |              |       |           |         |        |        |   |         |       
|                                                                           | Salaries and benefits            |                          |      |        |     |       |         | 73,953                |         |              |        | 3,774        |       |           |         |       |        |   |         | 77,727 |        
|                                                                           | Supplies                         |                          |      |        |     |       |         | 30,196                |         |              |        | 1,097        |       |           |         |       |        |   |         | 31,293 |        
|                                                                           | Other operating expenses         |                          |      |        |     |       |         | 67,683                |         |              |        | 1,901        |       |           |         |       |        |   |         | 69,584 |        
|                                                                           | Provision for bad debts          |                          |      |        |     |       |         | 15,828                |         |              |        | 946          |       |           |         |       |        |   |         | 16,774 |        
|                                                                           | Interest, net                    |                          |      | 14,408  |     |       |         | 95                    |         |              |        | 1,087        |       |           |         | (1,087 | )      |   |         | 14,503 |        
|                                                                           | Depreciation and amortization    |                          |      | 1,059   |     |       |         | 9,083                 |         |              |        | 346          |       |           |         |       |        |   |         | 10,488 |        
|                                                                           | Management fees                  |                          |      |        |     |       |         |                      |         |              |        | 214          |       |           |         | (214   | )      |   |         |       |        
|                                                                           | Equity in earnings of affiliates |                          |      | (14,669 | )   |       |         |                      |         |              |        |             |       |           |         | 14,669 |        |   |         |       |        
|                                                                           |                                  |                          |      |         |     |       |         |                       |         |              |        |              |       |           |         |        |        |   |         |       
|                                                                           |                                  | Total costs and expenses |      |         | 798 |       |         |                       | 196,838 |              |        |              | 9,365 |           |         |        | 13,368 |   |         |        | 220,369 | 
|Earnings (loss) from operations before
minority interests and income taxes |                                  |                          | (798 | )       |     |       | 13,322  |                       |         |              | 1,570  |              |       |           | (13,582 | )      |        |   | 512     |       
|Minority interests                                                         |                                  |                          |     |         |     |       | 223     |                       |         |              |       |              |       |           |        |        |        |   | 223     |       
|                                                                           |                                  |                          |      |         |     |       |         |                       |         |              |        |              |       |           |         |        |        |   |         |       
|Earnings (loss) from operations before income taxes                        |                                  |                          | (798 | )       |     |       | 13,099  |                       |         |              | 1,570  |              |       |           | (13,582 | )      |        |   | 289     |       
|Income tax expense                                                         |                                  |                          |     |         |     |       |        |                       |         |              |       |              |       |           |        |        |        |   |        |       
|                                                                           |                                  |                          |      |         |     |       |         |                       |         |              |        |              |       |           |         |        |        |   |         |       
|Net earnings (loss)                                                        |                                  | $                        | (798 | )       |     | $     | 13,099  |                       |         | $            | 1,570  |              |       | $         | (13,582 | )      |        | $ | 289     |       
|                                                                           |                                  |                          |      |         |     |       |         |                       |         |              |        |              |       |           |         |        |        |   |         |       

11



---



##### Table of Contents



IASIS HEALTHCARE CORPORATION
NOTES TO UNAUDITED CONDENSED AND CONSOLIDATED
FINANCIAL STATEMENTS
(Continued)

IASIS Healthcare Corporation

Condensed Consolidating Statement of Cash Flows
for the Three Months Ended December 31, 2001 (unaudited)(in thousands)

|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |         |         |        |  
|------------------------------------ | ---------------------------------------------------------------------------------------------------- | --------------------------------------------------- | ------------------------------------------------------ | ------- | ------- | ----- | ----- | ------- | --------------------- | ------- | ------------ | ------ | ------------ | ---- | --------- | ------- | ------ | - | - | ------- | ------- | ------ | -
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         | Subsidiary Guarantors
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                      
|                                     |                                                                                                      |                                                     |                                                        |         | Parent  |       | 100%  |         | Non-100%              |         |              |        |              |      | Condensed
|                                     |                                                                                                      |                                                     |                                                        |         | Issuer  |       | Owned |         | Owned                 |         | Eliminations |        | Consolidated
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |             
|Cash flows from operating activities |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|                                     | Net earnings (loss)                                                                                  |                                                     | $                                                      | (798    | )       |       | $     | 13,099  |                       |         | $            | 1,570  |              |      | $         | (13,582 | )      |   | $ | 289     |        
|                                     | Adjustments to reconcile net earnings (loss) to net
cash provided by (used in) operating activities: |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |         |        
|                                     |                                                                                                      | Depreciation and amortization                       |                                                        |         | 1,059   |       |       |         | 9,083                 |         |              |        | 346          |      |           |         |       |   |   |         | 10,488  |       
|                                     |                                                                                                      | Minority interests                                  |                                                        |         |        |       |       |         | 223                   |         |              |        |             |      |           |         |       |   |   |         | 223     |       
|                                     |                                                                                                      | Gain on sale of property and equipment              |                                                        |         |        |       |       |         | (12                   | )       |              |        |             |      |           |         |       |   |   |         | (12     | )     
|                                     |                                                                                                      | Equity in earnings of affiliates                    |                                                        |         | (14,669 | )     |       |         |                      |         |              |        |             |      |           |         | 14,669 |   |   |         |        |       
|                                     |                                                                                                      | Changes in operating assets and liabilities:        |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |         |         |       
|                                     |                                                                                                      |                                                     | Accounts receivable                                    |         |         |      |       |         |                       | 483     |              |        |              | 229  |           |         |        |  |   |         |         | 712    |  
|                                     |                                                                                                      |                                                     | Inventories, prepaid expenses and other
current assets |         |         |      |       |         |                       | (5,501  | )            |        |              | (256 | )         |         |        |  |   |         |         | (5,757 | )
|                                     |                                                                                                      |                                                     | Accounts payable and other accrued
liabilities         |         |         | 8,496 |       |         |                       | (13,838 | )            |        |              | (65  | )         |         |        |  |   |         |         | (5,407 | )
|                                     |                                                                                                      |                                                     | Accrued loss on discontinued operations                |         |         |      |       |         |                       | (239    | )            |        |              |     |           |         |        |  |   |         |         | (239   | )
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|                                     |                                                                                                      | Net cash provided by (used in) operating
activities |                                                        |         | (5,912  | )     |       |         | 3,298                 |         |              |        | 1,824        |      |           |         | 1,087  |   |   |         | 297     |       
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|Cash flows from investing activities |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|                                     | Purchases of property and equipment                                                                  |                                                     |                                                        |        |         |       |       | (59,178 | )                     |         |              | (3,105 | )            |      |           |        |        |   |   | (62,283 | )      
|                                     | Proceeds from sale of property and equipment                                                         |                                                     |                                                        |        |         |       |       | 12      |                       |         |              |       |              |      |           |        |        |   |   | 12      |        
|                                     | Change in other assets                                                                               |                                                     |                                                        |        |         |       |       | (665    | )                     |         |              |       |              |      |           |        |        |   |   | (665    | )      
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|                                     |                                                                                                      | Net cash used in investing activities               |                                                        |         |        |       |       |         | (59,831               | )       |              |        | (3,105       | )    |           |         |       |   |   |         | (62,936 | )     
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|Cash flows from financing activities |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|                                     | Proceeds from issuance of common stock                                                               |                                                     |                                                        | 222     |         |       |       |        |                       |         |              |       |              |      |           |        |        |   |   | 222     |        
|                                     | Proceeds from senior bank debt borrowings                                                            |                                                     |                                                        | 94,600  |         |       |       |        |                       |         |              |       |              |      |           |        |        |   |   | 94,600  |        
|                                     | Payment of debt and capital leases                                                                   |                                                     |                                                        | (35,850 | )       |       |       | (64     | )                     |         |              |       |              |      |           |        |        |   |   | (35,914 | )      
|                                     | Change in intercompany balances with affiliates, net                                                 |                                                     |                                                        | (50,735 | )       |       |       | 50,541  |                       |         |              | 1,281  |              |      |           | (1,087  | )      |   |   |        |        
|                                     | Debt financing costs incurred                                                                        |                                                     |                                                        | (2,325  | )       |       |       |        |                       |         |              |       |              |      |           |        |        |   |   | (2,325  | )      
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|                                     |                                                                                                      | Net cash provided by (used in) financing activities |                                                        |         | 5,912   |       |       |         | 50,477                |         |              |        | 1,281        |      |           |         | (1,087 | ) |   |         | 56,583  |       
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|                                     | Decrease in cash and cash equivalents                                                                |                                                     |                                                        |        |         |       |       | (6,056  | )                     |         |              |       |              |      |           |        |        |   |   | (6,056  | )      
|                                     | Cash and cash equivalents at beginning of period                                                     |                                                     |                                                        |        |         |       |       | 6,056   |                       |         |              |       |              |      |           |        |        |   |   | 6,056   |        
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        
|                                     | Cash and cash equivalents at end of period                                                           |                                                     | $                                                      |        |         |       | $     |        |                       |         | $            |       |              |      | $         |        |        |   | $ |        |        
|                                     |                                                                                                      |                                                     |                                                        |         |         |       |       |         |                       |         |              |        |              |      |           |         |        |   |   |        

12



---



##### Table of Contents






Item 2.  Managements Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of financial condition and results
of operations should be read in conjunction with our unaudited condensed and
consolidated financial statements, the notes to our unaudited condensed and
consolidated financial statements and the other financial information appearing
elsewhere in this report. Data for the three months ended December 31, 2001 and
2000 has been derived from our unaudited condensed and consolidated financial
statements.

Forward Looking Statements

Some of the statements we make in this report are forward-looking within
the meaning of the federal securities laws, which are intended to be covered by
the safe harbors created thereby. Those forward-looking statements include all
statements that are not historical statements of fact and those regarding our
intent, belief or expectations including, but not limited to, the discussions
of our operating and growth strategy (including possible acquisitions and
dispositions), financing needs, projections of revenue, income or loss, capital
expenditures and future operations. Forward-looking statements involve known
and unknown risks and uncertainties that may cause actual results in future
periods to differ materially from those anticipated in the forward-looking
statements. Those risks and uncertainties include, among others, the risks and
uncertainties discussed under the caption Risk Factors in our Annual Report
on Form 10-K for the fiscal year ended September 30, 2001. Although we believe
that the assumptions underlying the forward-looking statements contained in
this report are reasonable, any of these assumptions could prove to be
inaccurate and, therefore, there can be no assurance that the forward-looking
statements included in this report will prove to be accurate. In light of the
significant uncertainties inherent in the forward-looking statements included
in this report, you should not regard the inclusion of such information as a
representation by us or any other person that our objectives and plans will be
achieved. We undertake no obligation to publicly release any revisions to any
forward-looking statements contained herein to reflect events and circumstances
occurring after the date hereof or to reflect the occurrence of unanticipated
events.

General

We are an owner and operator of acute care hospitals that develops and
operates networks of medium-sized hospitals in high-growth urban and suburban
markets. We operate our hospitals with a strong community focus by offering and
developing healthcare services to meet the needs of the markets we serve,
promoting strong relationships with physicians and working with local managed
care plans. At December 31, 2001, we owned or leased 14 hospitals with a total
of 2,092 beds in service. Our hospitals are located in four regions:



| |  |  | Salt Lake City, Utah;                                     
| | - |  | ----------------------------------------------------------
|
| |  |  | Phoenix, Arizona;                                         
|
| |  |  | Tampa-St. Petersburg, Florida; and                        
|
| |  |  | three cities in the State of Texas, including San Antonio.

We also operate five ambulatory surgery centers and a Medicaid managed health
plan called Health Choice, serving over 53,800 members in Arizona at December
31, 2001.

Net revenue is comprised of net patient service revenue and other revenue.
Net patient service revenue is reported net of contractual adjustments. The
adjustments principally result from differences between the hospitals
established charges and payment rates under Medicare, Medicaid and various
managed care organizations. Established hospital charges generally have
increased at a faster rate than the rate of increase for Medicare and Medicaid
payments. The calculation of appropriate payments from the Medicare and
Medicaid programs as well as terms governing agreements with other third party
payors are complex and subject to interpretation. As a result, there is at
least a reasonable possibility that recorded estimates will change by a
material amount in the near term. We believe that we are in material compliance
with all applicable laws and regulations and are not aware of any pending or
threatened investigations involving allegations of potential wrongdoing that
would have a material effect on our financial statements. Other revenue
includes revenue from Health Choice, medical office building rental
income and other miscellaneous revenue. Operating expenses consist of
salaries and benefits, supplies, other operating expenses and provision for bad
debts.

13



---



##### Table of Contents



Our hospitals net patient service revenue continues to be affected by an
increasing proportion of revenue being derived from fixed payment, higher
discount sources including Medicare, Medicaid, managed care organizations and
others. Fixed payment amounts are often based upon a diagnosis related group
code regardless of the cost incurred or the level of services provided. Our net
revenue, cash flows and earnings have been reduced by this trend toward fixed
rate reimbursement. We expect patient volumes from Medicare and Medicaid to
continue to increase due to the general aging of the population and expansion
of state Medicaid programs. Under the Balanced Budget Act of 1997,
reimbursement from Medicare and Medicaid was reduced from 1998 through 2001 and
will continue to be reduced as certain changes are phased in during 2002.
Certain of the rate reductions resulting from the Balanced Budget Act of 1997
are being mitigated by the Balanced Budget Refinement Act of 1999 and the
Medicare, Medicaid and SCHIP Benefit Improvement and Protection Act of 2000. It
is estimated that the Benefit Improvement and Protection Act will provide
approximately $35.0 billion in funding restorations to Medicare healthcare
providers over a period of five years, approximately one-third of which will go
to hospitals. Exclusive of Health Choice, the percentage of our net revenue
related to Medicare and Medicaid was approximately 37.5% for the three months
ended December 31, 2001.

Our net revenue also is affected by the trend toward performing more
services on an outpatient basis due to advances in medical technology and
pharmacology as well as cost containment pressures from Medicare, Medicaid,
managed care organizations and other sources of revenue. Approximately 39.1% of
our gross patient revenue during the three months ended December 31, 2001 was
generated from outpatient procedures.

Selected Operating Data

The following table sets forth certain unaudited operating data for each
of the periods presented.

|                                          |  |                    |         |                    |  |  |         |    
|----------------------------------------- |  | ------------------ | ------- | ------------------ |  |  | ------- | ---
|                                          |  | Three Months Ended |         | Three Months Ended
|                                          |  | December 31, 2001  |         | December 31, 2000 
|                                          |  |                    |         |                   
|Number of hospitals at end of period      |  |                    | 14      |                    |  |  | 15      |    
|Licensed beds at end of period            |  |                    | 2,520   |                    |  |  | 2,685   | (1)
|Beds in service at end of period          |  |                    | 2,092   |                    |  |  | 2,194   | (1)
|Average length of stay (days) (2)         |  |                    | 4.18    |                    |  |  | 4.36    |    
|Occupancy rates (average beds in
service) |  |                    | 40.3    | %                  |  |  | 43.2    | %  
|Admissions(3)                             |  |                    | 18,558  |                    |  |  | 20,006  |    
|Adjusted admissions(4)                    |  |                    | 31,065  |                    |  |  | 31,789  |    
|Patient days(5)                           |  |                    | 77,492  |                    |  |  | 87,260  |    
|Adjusted patient days(4)                  |  |                    | 126,415 |                    |  |  | 134,658 |    



---

|(1) |  | Includes 118 licensed beds and 71 beds in service at Rocky Mountain
Medical Center, opened on April 10, 2000 and closed on June 2, 2001.                                                                                                                                             
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) |  | Represents the average number of days that a patient stayed in our
hospitals.                                                                                                                                                                                                        
|   
|(3) |  | Represents the total number of patients admitted to our hospitals for
stays in excess of 23 hours. Management and investors use this number as
a general measure of inpatient volume.                                                                                                
|   
|(4) |  | Adjusted admissions and adjusted patient days are general measures of
combined inpatient and outpatient volume. We compute adjusted
admissions/patient days by multiplying admissions/patient days by gross
patient revenue and then dividing that number by gross inpatient
revenue.
|   
|(5) |  | Represents the number of days our beds were occupied over the period.                                                                                                                                                                                                                

14



---



##### Table of Contents



Results of Operations

The following table presents, for the periods indicated, information
expressed as a percentage of net revenue. Such information has been derived
from our unaudited condensed and consolidated statements of operations.

|                                                    |  |                    |       |                    |  |  |       |   
|--------------------------------------------------- |  | ------------------ | ----- | ------------------ |  |  | ----- | --
|                                                    |  | Three Months Ended |       | Three Months Ended
|                                                    |  | December 31, 2001  |       | December 31, 2000 
|                                                    |  |                    |       |                   
|Net revenue                                         |  |                    | 100.0 | %                  |  |  | 100.0 | % 
|Salaries and benefits                               |  |                    | 35.2  |                    |  |  | 35.1  |   
|Supplies                                            |  |                    | 14.1  |                    |  |  | 14.7  |   
|Other operating expenses                            |  |                    | 31.5  |                    |  |  | 29.6  |   
|Provision for bad debts                             |  |                    | 7.6   |                    |  |  | 7.9   |   
|                                                    |  |                    |       |                    |  |  |       |   
|Total operating expenses                            |  |                    | 88.4  |                    |  |  | 87.3  |   
|                                                    |  |                    |       |                    |  |  |       |   
|EBITDA (a)                                          |  |                    | 11.6  |                    |  |  | 12.7  |   
|Depreciation and amortization                       |  |                    | 4.8   |                    |  |  | 6.4   |   
|Interest, net                                       |  |                    | 6.6   |                    |  |  | 7.9   |   
|Minority interests                                  |  |                    | 0.1   |                    |  |  |      |   
|                                                    |  |                    |       |                    |  |  |       |   
|Earnings (loss) from operations
before income taxes |  |                    | 0.1   |                    |  |  | (1.6  | ) 
|Income tax expense                                  |  |                    |      |                    |  |  |      |   
|                                                    |  |                    |       |                    |  |  |       |   
|Net earnings (loss)                                 |  |                    | 0.1   | %                  |  |  | (1.6  | )%
|                                                    |  |                    |       |                    |  |  |       |   



---

|(a) |  | EBITDA represents earnings from operations before interest expense,
minority interests, income taxes and depreciation and amortization.
Although EBITDA should not be considered in isolation or as a
substitute for net earnings, operating cash flows or other cash flow
statement data determined in accordance with accounting principles
generally accepted in the United States, management understands that
EBITDA is commonly used to evaluate a companys financial performance,
especially in evaluating healthcare companies. EBITDA, as presented,
may not be comparable to similarly titled measures of other companies.
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Three Months Ended December 31, 2001 Compared to Three Months Ended December
31, 2000

Net revenue for the three months ended December 31, 2001 was $220.9
million, an increase of $1.5 million, or 0.7%, from $219.4 million for same
period in 2000. The increase in net revenue was a combination of a decrease of
$4.9 million in net revenue from hospital operations, which we refer to as our
acute care service segment in our financial statements, and an increase of $6.4
million in net revenue from Health Choice.

Net revenue from our hospital operations for the three months ended
December 31, 2001 was $187.7 million, down $4.9 million, or 2.5%, from $192.6
million for the same period in 2000. Excluding net revenue derived from Rocky
Mountain Medical Center of $4.1 million for the three months ended December 31,
2000, same facility net revenue from our hospital operations decreased $0.8
million, or 0.4%, from period to period. Rocky Mountain Medical Center was
closed on June 2, 2001, as discussed below. The decrease in net revenue was due
to lower volume in our hospital operations, particularly our Arizona market, as
discussed below. Our net patient
revenue per adjusted patient day increased 4.6% for the three months ended
December 31, 2001, compared to the same period in 2000, excluding Rocky Mountain Medical Center.

In our Arizona market, admissions and patient days declined significantly
during the three months ended December 31, 2001 compared to the same period in
2000. The decline in volume in that market was due primarily to the closure of
two sub-acute units in the third and fourth quarters of fiscal 2001, turnover
in management at

15



---



##### Table of Contents



certain of the hospitals during fiscal 2001, the termination of a
capitated contract with a managed care organization at two of the hospitals in
March 2001 and renegotiation of the contract to a per diem arrangement, delays
in seasonal illnesses in the market and the delayed arrival of winter
residents. During the fourth quarter of fiscal 2001, we hired new management
for our hospital operations in this market. Prior to March 2001, we had a
significant capitated Medicare contract in this market under which we
experienced an increase in utilization and other costs without corresponding
increases in net revenue. In an effort to improve operating results, effective
March 1, 2001, we terminated the capitated contract and renegotiated this
contract to a per diem arrangement under which we generally are paid a fixed
payment for each day a patient receives care in our hospitals. Under the per
diem contract, the length of stay for the related patients has dropped compared
to prior periods. This decline has negatively impacted the hospitals
profitability under the contract. In response to the decline in volume and net
revenue in the Arizona market, we have focused on obtaining favorable price
increases, growing profitable product lines and eliminating unprofitable
product lines, recruiting additional primary care physicians to improve the
patient and service mix and reducing our operating expenses. As of December
31, 2001, we had reduced our full-time equivalent employees by 13% compared to
September 30, 2001. In addition, in December 2001 we obtained discounts for
certain supplies and reduced other operating expenses. The benefit of the
reductions in these expenses should begin to be reflected in the operating
results of the quarter ended March 31, 2002.

Admissions decreased 6.3% from 19,796 for the three months ended December
31, 2000, excluding Rocky Mountain Medical Center, to 18,558 for the same
period in 2001, and patient days decreased 10.4% from 86,442 for the three
months ended December 31, 2000, excluding Rocky Mountain Medical Center, to
77,492 for the same period in 2001. Adjusted admissions decreased 1.0% from
31,391 for the three months ended December 31, 2000, excluding Rocky Mountain
Medical Center, to 31,065 for the same period in 2001, and adjusted patient
days decreased 5.0% from 133,107 for the three months ended December 31, 2000,
excluding Rocky Mountain Medical Center, to 126,415 for the same period in
2001. Volume was negatively impacted during the three months ended December
31, 2001 by the results from our Arizona market, as discussed above, as well as
the closure of sub-acute units in other markets during the prior year. The average length of stay resulting from admissions and patient days
decreased 4.4% from 4.37 days for the three months ended December 31, 2000,
excluding Rocky Mountain Medical Center, to 4.18 days for the same period in
2001. This decrease in length of stay was attributable in part to the
transition of the managed care contract in Arizona from a capitated contract to
a per diem contract, improved case management, growth in services requiring
shorter length of stays, closure of sub-acute units and changes in technology,
pharmacology and clinical practices.

Net revenue from Health Choice was $33.2 million for the three months
ended December 31, 2001, an increase of $6.4 million, or 23.9%, from $26.8
million for the same period in 2000. Covered lives under this prepaid Medicaid
plan have increased 27.6% from 42,178 at December 31, 2000 to 53,833 at
December 31, 2001. The increase in covered lives has positively impacted Health
Choices net revenue for the three months ended December 31, 2001 compared to
the same period in 2000. Our growth in covered lives is due primarily to a
change in the eligibility standards in Arizona that increased the
Medicaid-eligible population.

Operating expenses increased $3.8 million from $191.6 million for the
three months ended December 31, 2000 to $195.4 million for the same period in
2001. Operating expenses as a percentage of net revenue were 88.4% for the
three months ended December 31, 2001, compared to 87.3% for the same period in
2000. Excluding Rocky Mountain Medical Center, operating expenses as a
percentage of net revenue were 85.5% for the three months ended December 31,
2000.

Operating expenses from our hospital operations for the three months ended
December 31, 2001 were $163.3 million, a decrease of $2.7 million, or 1.6%,
from $166.0 million for the same period in 2000. This decrease was comprised
of a $7.6 million decrease in operating expenses from Rocky Mountain Medical
Center due to its closure, offset by a $4.9 million increase in operating
expenses due to volume growth in some of our markets, increases in salaries and
health insurance benefit costs and the increased cost of professional liability
insurance.

Operating expenses from our hospital operations as a percentage of net
revenue were 87.0% for the three months ended December 31, 2001 compared to
84.1% for the same period in 2000, excluding Rocky Mountain Medical Center.
This increase was due to a combination of increased salaries and benefits
expense, provision for bad debts and other operating expenses as a percentage
of net revenue, offset partially by a decrease in supplies

16



---



##### Table of Contents



expense as a percentage of net revenue. Salaries and wages, contract
labor and benefits expense as a percentage of net revenue increased 1.8% from
period to period. Salaries expense increased by approximately $2.4 million for
the three months ended December 31, 2001 compared to the same period in 2000
due primarily to general wage inflation and increased staffing at our corporate
office. Corporate salaries increased by approximately $0.5 million for the
three months ended December 31, 2001 compared to the same period in 2000 as a
result of building our corporate support infrastructure. Contract labor
decreased by $0.8 million for the three months ended December 31, 2001 compared
to the same period in 2000 due primarily to a decline in the use of contract
labor in our Arizona market as a result of a decline in patient volume.
Benefits expense increased by approximately $1.4 million for the three months
ended December 31, 2001 compared to the same period in 2000 due primarily to
the increased cost and utilization of healthcare benefits for employees.
Changes in the employee healthcare benefits plan have been initiated in the
second quarter that are expected to reduce the rate of increases in healthcare benefit costs.
Provision for bad debts as a percentage of net revenue increased 0.4% from
period to period due primarily to self-pay inpatient volume, principally
through our emergency room services, and an increase in self-pay accounts
receivable resulting from balances due after insurance payments, such as
deductibles and co-insurance. Supplies expense as a percentage of net revenue
decreased 0.1% from period to period due to increasing compliance with our
group purchasing contract and decreased supplies utilization beginning in the
fourth quarter of fiscal 2001. Other operating expenses as a percentage of net
revenue increased 0.9% from period to period due primarily to an overall
increase in insurance premiums generally and a significant increase in our
self-insured retention and premiums for professional liability insurance
effective October 2001. Insurance expense increased by approximately $1.9
million for the three months ended December 31, 2001 compared to the same
period in 2000, and we expect our other operating expenses to continue to be
negatively impacted for the remainder of fiscal year 2002 by these insurance
expense increases. As a result of the October 2001 acquisition of the land and
buildings at two of our facilities in Arizona previously operated under
long-term leases, $1.6 million in rent expense for the three months ended
December 31, 2000 was not incurred in the current quarter.

We opened Rocky Mountain Medical Center in Salt Lake City, Utah on April
10, 2000 with 118 licensed beds and 71 beds in service. Our census levels and
net revenue were slow to grow and significantly lower than we expected prior to
opening the hospital primarily as a result of what we believe to be
exclusionary contracting practices pursued in the Salt Lake City market by a
competitor. As a result, we closed Rocky Mountain Medical Center on June 2,
2001 and recorded asset revaluation and closure costs of $11.9 million during
the year ended September 30, 2001, as discussed below. We have classified the
assets at Rocky Mountain Medical Center as held for sale and currently expect
to sell these assets no later than September 30, 2002. In addition, as a result
of the exclusionary contracting practices that we believe had a material
adverse effect on the business and operations of Rocky Mountain Medical Center,
we filed a lawsuit against the competitor seeking damages and other remedies.
The lawsuit is currently pending.

During the three months ended December 31, 2001, Rocky Mountain Medical
Center generated no net revenue and incurred other operating expenses of
$30,000. During the three months ended December 31, 2000, Rocky Mountain
Medical Center generated net revenue of $4.1 million and incurred operating
expenses of $7.6 million, resulting in an EBITDA loss of $3.5 million.
Operating expenses for the three months ended December 31, 2000, consisted of
$2.5 million in salaries and benefits, $600,000 in supplies, $1.3 million in
provision for bad debts and $3.2 million in other operating expenses. Other
operating expenses included costs for purchased services, rents and leases,
utilities, marketing, insurance and other expenses, including professional fees
associated with the lawsuit noted above of approximately $473,000 for the three
months ended December 31, 2000.

Operating expenses for Health Choice increased $6.5 million to $32.1
million for the three months ended December 31, 2001 compared to $25.6 million
for the same period in 2000. Operating expenses as a percentage of net revenue
for Health Choice were 96.5% for the three months ended December 31, 2001 and
95.6% for the same period in 2000. The increase in operating expenses was due
to the incremental cost of increased enrollment and a slight increase in the
medical loss ratio due in part to the higher level of care required for new
members upon entry to the network. As these members receive healthcare under
the plan, their health status should improve and the medical loss ratio should
decline accordingly.

EBITDA was $25.5 million, or 11.5% of net revenue, for the three months
ended December 31, 2001, compared to $27.8 million, or 12.7% of net revenue,
for the same period in 2000. Excluding results from Rocky Mountain Medical
Center for the three months ended December 31, 2000, net revenue and EBITDA
were $215.3 million and $31.3 million, respectively, resulting in an EBITDA
margin of 14.5% for the prior year period.

17



---



##### Table of Contents



EBITDA for hospital operations, excluding Rocky Mountain Medical Center,
was $24.4 million, or 13.0% of net revenue, for the three months ended December
31, 2001, compared to $30.1 million, or 16.0% of net revenue, for the same
period in 2000. The decline in the EBITDA margin for hospital operations,
excluding the effect of Rocky Mountain Medical Center, was due primarily to
lower volume and net revenue in the Arizona market, increases in salaries and
employee health insurance costs and the increased cost of professional
liability insurance as noted above.

Health Choice, our Medicaid managed health plan, has a significantly lower
EBITDA margin than hospital operations. EBITDA for Health Choice was $1.1
million, or 3.4% of net revenue, for the three months ended December 31, 2001,
compared to $1.2 million for the same period in 2000, representing 4.4% of net
revenue. The decline in EBITDA was due to increased costs as noted above.

Depreciation and amortization expense decreased $3.6 million from $14.1
million for the three months ended December 31, 2000 to $10.5 million for the
same period in 2001. Effective October 1, 2001, we adopted Statement of
Financial Accounting Standards (SFAS) No. 142, Goodwill and Other Intangible
Assets,which eliminates amortization for goodwill and other intangible assets
with indefinite lives, as discussed below. The adoption of this accounting
standard was responsible for a $3.0 million decrease in amortization expense
for the three months ended December 31, 2001 compared to the same period in
2000.

Interest expense decreased $2.7 million from $17.2 million for the three
months ended December 31, 2000 to $14.5 million for the same period in 2001 due
to interest rate decreases during fiscal year 2001. Borrowings under our bank
credit facility bear interest at variable rates, and the weighted average
interest rate of outstanding borrowings under the bank credit facility was
approximately 6.9% for the three months ended December 31, 2001 compared to
11.1% for the same period in 2000. The decrease in interest expense due to
lower interest rates was partially offset by the expense of additional
borrowings of approximately $55.0 million on October 15, 2001 for the
acquisition of the land and buildings at two of our facilities in Arizona
previously operated under long-term operating leases.

We recorded no provision for income taxes for the three months ended
December 31, 2001 due to the use of deferred tax assets that were previously
reserved with a valuation allowance. We recorded no provision for income taxes
for the three months ended December 31, 2000 due to the uncertainty of
realizing a tax benefit related to the losses incurred.

We recorded no preferred stock dividends during the three months ended
December 31, 2001. We recorded a reversal of preferred stock dividends of
$25.3 million during the three months ended December 31, 2000. The preferred
stock, which was exchanged for shares of our common stock on the basis of ten
common shares for each preferred share in October 2000, was mandatorily
redeemable and dividends were payable in shares of our common stock. The
preferred stock was exchanged for common stock without benefit to the preferred
stockholders of the accrued dividends, therefore, the accrual of dividends was
reversed in the first quarter of fiscal 2001. Net earnings attributable to
common stockholders after the effect of the preferred stock dividend reversal
for the three months ended December 31, 2000 was $21.7 million.

Implementation of New Accounting Pronouncement

We adopted SFAS No. 142, Goodwill and Other Intangible Assets,effective
October 1, 2001. Under SFAS No. 142, goodwill and intangible assets deemed to
have indefinite lives will no longer be amortized but will be subject to
impairment tests on an annual basis, or more frequently if certain indicators
arise. Other intangible assets will continue to be amortized over their useful
lives. We are required to complete our transitional impairment test of
existing goodwill by March 31, 2002. As of the date hereof, we have not
completed the impairment testing of goodwill and have not yet determined what
the effect of these tests will be on our earnings and financial position.
Application of the nonamortization provisions of SFAS No. 142 is expected to
result in an increase to pre-tax net earnings of approximately $11.8 million
per year. Excluding the amortization of goodwill, the net loss would have been
$0.6 million for the three months ended December 31, 2000.

18



---



##### Table of Contents



Asset Revaluation and Closure Costs

Asset Revaluation

During the year ended September 30, 2001, we closed Rocky Mountain Medical
Center and recorded a pre-tax asset revaluation charge of approximately $2.8
million related to the revaluation of net assets in conjunction with their
classification as held for sale. At December 31, 2001, Rocky Mountain Medical
Center net assets held for sale and expected to be sold no later than September
30, 2002, totaled approximately $22.0 million, net of the asset revaluation
allowance. There can be no assurance, however, that we will recover the entire
amount. Net revenue and pre-tax losses from Rocky Mountain Medical Center were
$4.1 million and $5.8 million, respectively, for the three months ended
December 31, 2000.

Closure Costs

During the year ended September 30, 2001, we adopted and implemented an
exit plan and recorded pre-tax closure charges of approximately $9.1 million
with respect to the closure of Rocky Mountain Medical Center. These charges
were comprised of approximately $1.5 million in severance and related costs,
$3.5 million in facility and lease termination costs, $2.4 million in contract
termination costs and $1.7 million in other exit costs. This closure plan
included the involuntary termination of approximately 200 hospital and business
office personnel, which was completed by September 30, 2001. During the three
months ended December 31, 2001, we paid a total of $1.1 million in closure
costs, including approximately $200,000 in severance and related costs,
$400,000 in facility and lease termination costs, $200,000 in contract
termination costs and $300,000 in other exit costs related to the closure of
Rocky Mountain Medical Center. At December 31, 2001, accrued closure costs
totaled approximately $4.6 million and consisted of approximately $100,000 in
severance and related costs, $2.3 million in facility and lease termination
costs, $1.8 million in contract termination costs and $400,000 in other exit
costs.

Liquidity and Capital Resources

At December 31, 2001, we had $70.3 million in working capital, compared to
$69.6 million at September 30, 2001. We generated cash of $0.3 million in
operating activities during the three months ended December 31, 2001, compared
to using $6.0 million of cash during the three months ended December 31, 2000.
Net accounts receivable decreased $0.5 million from $147.8 million at September
30, 2001 to $147.3 million at December 31, 2001 and amounted to approximately
71 days of net revenue outstanding at December 31, 2001 compared to 70 days at
September 30, 2001. The fiscal intermediaries have been unable to provide data
necessary to complete cost reports for periods after the August 1, 2000
implementation date of the outpatient prospective payment system, resulting in
industry-wide extensions of the due dates for filing cost reports for such
periods. These delays have caused our Medicare settlement receivables to
increase from approximately $3.0 million at September 30, 2000 to approximately
$12.5 million at September 30, 2001 and to approximately $14.1 million at
December 31, 2001. Excluding Medicare settlement receivables, our days of net
revenue outstanding at both December 31, 2001 and September 30, 2001 were 64.
Prepaid expenses and other current assets increased $4.9 million from $15.5
million at September 30, 2001 to $20.4 million at December 31, 2001 due in part
to a prepaid information systems maintenance contract.

Investing activities used $62.9 million during the three months ended
December 31, 2001. Capital expenditures for the three months ended December
31, 2001 were approximately $62.3 million, including $55.3 million for the
acquisition of the land and buildings at two of our facilities previously
operated under long-term leases and $3.7 million for renovation and expansion
at two of our hospitals. We have budgeted capital expenditures for the
remainder of fiscal year 2002 of approximately $33.0 million to $38.0 million,
including $18.7 million for renovation and expansion at our facilities and
$14.3 million to $19.3 million for new equipment at our facilities. The capital
expenditures budget for fiscal year 2002 is based upon our analysis of various
factors, many of which are beyond our control, and we cannot assure you that
our capital expenditures will not significantly exceed budgeted amounts.

19



---



##### Table of Contents



Financing activities during the three months ended December 31, 2001
provided net cash of $56.6 million due primarily to borrowings of $30.0 million
under a new incremental senior secured term loan and borrowings under our
revolving credit facility for the acquisition of the land and buildings at two
of our facilities previously operated under long-term leases for an aggregate
purchase price of approximately $55.3 million. During the three months ended
December 31, 2001, we borrowed $94.6 million pursuant to the terms of our bank
credit facility, repaid $6.3 million in outstanding borrowings pursuant to the
terms of our bank credit facility and capital lease obligations and made
voluntary prepayments of $29.6 million pursuant to the terms of our revolving
credit facility. During the next twelve months, we are required to repay $19.6
million under our bank credit facility. During the three months ended December
31, 2001, we received proceeds of approximately $200,000 from the issuance of
23,334 shares of common stock to David R. White, our President and Chief
Executive Officer.

Effective October 15, 1999, we entered into a bank credit facility through
which a syndicate of lenders made a total of $455.0 million available to us in
the form of an $80.0 million tranche A term loan, a $250.0 million tranche B
term loan and a $125.0 million revolving credit facility. Proceeds from the
tranche A and tranche B term loans were used in conjunction with the
recapitalization and acquisition transactions. The $125.0 million revolving
credit facility is available for working capital and other general corporate
purposes. The bank credit facility requires that we comply with various
financial ratios and tests and contains covenants limiting our ability to,
among other things, incur debt, engage in acquisitions or mergers, sell assets,
make investments or capital expenditures, make distributions or stock
repurchases and pay dividends. The bank credit facility is guaranteed by our
subsidiaries and these guaranties are secured by a pledge of substantially all
of the subsidiaries assets. Effective October 5, 2001, we amended our bank
credit facility to provide for an additional $30.0 million incremental senior
secured term loan on substantially the same terms and conditions as our current
existing bank credit facility. The new incremental term loan was used solely to
fund the purchase on October 15, 2001, of the land and buildings at two of our
facilities in Arizona previously operated under long-term leases and related
costs and expenses. The amended bank credit facility also provided for
revisions to certain financial covenants.

At December 31, 2001, amounts outstanding under the tranche A, tranche B
and incremental term loans were $68.8 million, $244.4 million and $30.0
million, respectively, and we had $35.0 million outstanding under our revolving
credit facility. The revolving credit facility includes a $75.0 million
sub-limit for letters of credit that may be issued by us and, at December 31,
2001, we had issued $30.5 million in letters of credit. The loans under the
bank credit facility bear interest at variable rates at specified margins above
either the agent banks alternate base rate or its reserve-adjusted Eurodollar
rate. The weighted average interest rate of outstanding borrowings under the
bank credit facility was approximately 6.9% for the three months ended December
31, 2001. On October 15, 2001, we acquired the land and buildings at two of our
facilities previously operated under long-term leases for an aggregate purchase
price of approximately $55.3 million. The acquisition will eliminate $7.4
million in rent expense in fiscal year 2002. The purchase price was financed by
the $30.0 million new incremental senior secured term loan and borrowings under
our revolving credit facility. At February 14, 2002, we had
drawn $30.0 million
under our revolving credit facility and had issued $31.2 million in letters of
credit, resulting in remaining availability under the revolving credit facility
of $63.8 million.

On October 13, 1999, we issued $230.0 million of 13% senior subordinated
notes due 2009. On May 25, 2000, we exchanged all of our outstanding 13% senior
subordinated notes due 2009 for 13% senior subordinated exchange notes due 2009
that have been registered under the Securities Act of 1933, as amended. The
notes are unsecured obligations and are subordinated in right of payment to all
of our existing and future senior indebtedness. If a change in control occurs,
as defined in the indenture, each holder of the notes will have the right to
require us to repurchase all or any part of that holders notes in cash at 101%
of the aggregate principal amount of notes repurchased plus accrued and unpaid
interest to the date of purchase. Except with respect to a change of control,
we are not required to make mandatory redemption or sinking fund payments with
respect to the notes. At December 31, 2001, all of the subsidiaries fully and
unconditionally guaranteed the notes on a joint and several basis. The
indenture for the notes contains certain covenants, including but not limited
to, restrictions on new indebtedness, asset sales, capital expenditures,
dividends and our ability to merge or consolidate.

Our liquidity and capital resources have been negatively affected by Rocky
Mountain Medical Center, which was closed on June 2, 2001. During the three
months ended December 31, 2001, at Rocky Mountain Medical Center we paid a
total of $1.1 million in closure costs, including approximately $200,000 in
severance and related costs, $400,000 in facility and lease termination costs,
$200,000 in contract termination costs and $300,000 in other exit costs related
to the closure of Rocky Mountain Medical Center.

20



---



##### Table of Contents



In connection with the recapitalization transaction with Paracelsus
Healthcare Corporation and the acquisition transaction with Tenet Healthcare
Corporation in October 1999, we did not assume any liability or obligation of
Paracelsus or Tenet owed to payors, including private insurers and government
payors such as Medicare and Medicaid programs. We also did not assume any cost
report reimbursements, settlements, repayments or fines, if any, to the extent
they relate to periods prior to the respective closing dates of these
transactions. Our agreements with Paracelsus and Tenet include customary
indemnification and hold harmless provisions for any damages we incur relating
to these types of excluded liabilities.

Subsequent to the recapitalization transaction, Paracelsus filed a
petition for relief pursuant to Chapter 11 of the United States Bankruptcy
Code. In October 2000, Paracelsus filed with the United States Bankruptcy Court
a Disclosure Statement and a Plan of Reorganization under Chapter 11 of the
Bankruptcy Code. We filed timely objections and proofs of claim against
Paracelsus. In response to our objections and proofs of claim, and in exchange
for our agreement to withdraw our objections to its Plan of Reorganization, we
negotiated a resolution with Paracelsus whereby Paracelsus agreed that the
restructured debtor would assume all indemnification obligations of Paracelsus
under our recapitalization agreement. The bankruptcy court confirmed this plan
on June 27, 2001. We also continue to have indemnification rights against
other subsidiaries of Paracelsus that are also parties to our recapitalization
agreement, which rights are not affected by the bankruptcy proceeding.

As of December 31, 2001, we provided performance guaranties in the form of
a surety bond in the amount of $9.4 million and a letter of credit in the
amount of $11.2 million for the benefit of the Arizona Health Care Cost
Containment System to support our obligations under the Health Choice contract
to provide and pay for healthcare services. The amount of the performance
guaranty that the Arizona Health Care Cost Containment System requires is based
upon the membership in the plan and the related capitation paid to us.

Based upon our current level of operations and anticipated growth, we
believe that cash generated from operations and amounts available under the
revolving credit facility will be adequate to meet our anticipated debt service
requirements, capital expenditures and working capital needs for the next 12
months. We cannot assure you, however, that our business will generate
sufficient cash flow from operations or that future borrowings will be
available under our bank credit facility, or otherwise, to enable us to grow
our business, service our indebtedness, including the bank credit facility and
our senior subordinated exchange notes, or make anticipated capital
expenditures. One element of our business strategy is expansion through the
acquisition of hospitals in existing and new high-growth markets. The
completion of acquisitions may result in the incurrence of, or assumption by
us, of additional indebtedness. Our future operating performance, ability to
service or refinance the senior subordinated exchange notes and ability to
service and extend or refinance the bank credit facility will be subject to
future economic conditions and to financial, business and other factors, many
of which are beyond our control.




Item 3.  Quantitative and Qualitative Disclosures About Market Risk

During the three months ended December 31, 2001, there were no material
changes to our quantitative and qualitative disclosures about the market risk
associated with financial instruments as described in our Annual Report on Form
10-K for the year ended September 30, 2001. At December 31, 2001, the fair
market value of our outstanding senior subordinated exchange notes was $253.0
million, based upon quoted market prices as of that date.




PART II

OTHER INFORMATION




Item 2.  Changes in Securities and Use of Proceeds.

On December 28, 2001, we sold 23,334 shares of our common stock to our
David R. White, our President
and Chief Executive Officer, for aggregate consideration of $222,140. The
shares were issued in a private transaction exempt under Section 4(2) of the
Securities Act, which exempts sales of securities that do not involve a public
offering.

21



---



##### Table of Contents






Item 6.  Exhibits and Reports on Form 8-K

|     |  |                                                  
|---- |  | -------------------------------------------------
|(a)  |  | List of Exhibits:                                
|10.1 |  | Senior Executive Officer Compensation Plan       
|99.1 |  | Odessa Regional Hospital, LP Financial Statements
|(b)  |  | Reports on Form 8-K:                             



| |                                                                                                                                                                                                                                                                           
| | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | On October 10, 2001, the Company filed a Current Report on Form 8-K to
report that it had issued a press release announcing the amendment of its
bank credit facility and the proposed acquisition of the land and
buildings with respect to two of its Arizona hospitals.
|
| | On November 27, 2001, the Company filed a Current Report on Form 8-K to
report that it had issued a press release announcing the date of the
online web simulcast of its fiscal year 2001 earnings conference call.                                                       
|
| | On December 6, 2001, the Company filed a Current Report on Form 8-K to
report that it had issued a press release announcing its earnings for the
fourth quarter and fiscal year ended September 30, 2001.                                                                 

22



---



##### Table of Contents






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

|                        |  |                              |  |                                                            
|----------------------- |  | ---------------------------- |  | -----------------------------------------------------------
|                        |  | IASIS HEALTHCARE CORPORATION
|                       
|                        |  |                              |  |                                                            
|                       
|Date: February 14, 2002 |  | By:                          |  | /s/ W. Carl WhitmerW. Carl Whitmer, Chief Financial Officer

23



---



##### Table of Contents






EXHIBIT INDEX

|            |  |                                                            
|----------- |  | -----------------------------------------------------------
|Exhibit No. |  | Description                                                
|            |  |                                                            
|10.1        |  | Senior Executive Compensation Plan                         
|99.1        |  | Odessa Regional Hospital, LP Unaudited Financial Statements